These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21036108)

  • 21. Severe hemolysis associated with use of the Impella LP 2.5 mechanical assist device.
    Sibbald M; Džavík V
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):840-4. PubMed ID: 22511273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impella 2.5 assisted balloon aortic valvuloplasty and percutaneous coronary intervention as a bridge to heart transplantation.
    Badawi RA; Grise MA; Thornton SN
    J Invasive Cardiol; 2012 May; 24(5):229-30. PubMed ID: 22562918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficient revascularization of totally blocked left branch of coronary artery in cardiogenic shock complicating myocardial infarction of anterior and side heart wall].
    Kawecki D; Kondys M; Kulej J; Michalewska-Włudarczyk A; Tomasik A; Switalska-Janiczek I
    Kardiol Pol; 2006 Dec; 64(12):1449-51; discussion 1451-2. PubMed ID: 17206548
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanical versus pharmacologic support for cardiogenic shock.
    Dhar G; Jolly N
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):626-9. PubMed ID: 20049971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical use of temporary percutaneous left ventricular assist devices.
    Froesch P; Martinelli M; Meier P; Cook S; Hullin R; Windecker S; Mohacsi P; Meier B
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):304-13. PubMed ID: 21766420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit.
    Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E
    Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Complex percutaneous coronary intervention of left main coronary artery in patient with acute myocardial infarction complicated with cardiogenic shock].
    Dobrzycki S; Prokopczuk P; Kamiński K
    Kardiol Pol; 2006 Jul; 64(7):754-6; discussion 757. PubMed ID: 16886136
    [No Abstract]   [Full Text] [Related]  

  • 30. Percutaneous Coronary Intervention Under Cover of Left Ventricular Assist Device (Impella 2.5).
    Iftikhar I; Khan HS; Kayani AM; Shahzad H
    J Coll Physicians Surg Pak; 2015 Oct; 25 Suppl 2():S78-80. PubMed ID: 26522210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary percutaneous coronary intervention for the treatment of a patient with cardiogenic shock due to acute total occlusion of unprotected left main coronary artery without supportive collateral flow.
    Çetin M; Kocaman SA; Bostan M; Erdogan T; Satiroglu Ö
    Future Cardiol; 2011 Nov; 7(6):749-55. PubMed ID: 22050061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shock.
    Cyrus T; Mathews SJ; Lasala JM
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S1-6. PubMed ID: 20333708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impella assisted transradial coronary intervention in patients with acute coronary syndromes and cardiogenic shock: case series.
    Bell BP; Iqtidar AF; Pyne CT
    Catheter Cardiovasc Interv; 2011 Nov; 78(6):880-5. PubMed ID: 21523889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
    Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
    Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impella LP 5.0 as a bridge to long-term circulatory support.
    Samoukovic G; Rosu C; Giannetti N; Cecere R
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):682-3. PubMed ID: 19254945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous ventricular assist device support during off-pump surgical coronary revascularization.
    Gregoric ID; Poglajen G; Span M; Frazier OH; Loyalka P; Kar B
    Ann Thorac Surg; 2008 Aug; 86(2):637-9. PubMed ID: 18640347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary Impella insertion under regional nerve block: A case report.
    Raghunathan D; Hernandez N; Rajagopal K; Jumean M
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):E108-E110. PubMed ID: 31228327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: related factors.
    Conde-Vela C; Moreno R; Hernández R; Pérez-Vizcayno MJ; Alfonso F; Escaned J; Sabaté M; Bañuelos C; Macaya C
    Int J Cardiol; 2007 Dec; 123(1):29-33. PubMed ID: 17303267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.